INS and type 2 diabetes mellitus: In patients with insulin-treated type 1 and type 2 diabetes the use of the GlucoonlineTM system resulted in a 0.38% decrease in HbA1c from baseline and a higher proportion of patients achieving a HbA1c target level of less than 7%, as compared with standard of care.